Cytomegalovirus and Breastfeeding Key Facts
Cytomegalovirus and Breastfeeding Key Facts Cytomegalovirus (CMV) is a common virus that belongs to the herpesvirus family. Many people are infected with CMV at some point in their lives, often without experiencing symptoms. While CMV typically remains dormant in healthy individuals, it can pose significant risks to certain populations, including newborns and immunocompromised persons. Understanding the relationship between CMV and breastfeeding is essential for new mothers and healthcare providers aiming to ensure infant safety while promoting healthy bonding and nutrition.
In infants, CMV can be transmitted in various ways, with breastfeeding being one of the possible routes. The virus can be present in the mother’s breast milk, especially if she has a primary infection or a reactivation of a dormant virus. However, the mere presence of CMV in breast milk does not automatically mean that an infant will become infected or develop illness. Most healthy full-term infants are naturally protected, and the benefits of breastfeeding—such as immune support, bonding, and nutrition—generally outweigh the risks associated with CMV transmission.
When it comes to preterm or immunocompromised infants, the situation becomes more nuanced. These vulnerable groups are at higher risk of developing symptomatic CMV infection, which can lead to complications like pneumonia, hepatitis, or neurological issues. For preterm babies, especially those born before 32 weeks of gestation, CMV transmitted through breast milk can sometimes cause more significant health problems. In such cases, healthcare providers may recommend pasteurizing breast milk, which inactivates the virus while preserving most of its beneficial properties.
Research indicates that, for healthy full-term infants, the risk of severe CMV disease from breast milk is minimal. Many health organizations, including the World Health Organization and the American Academy of Pediatrics, advocate for continued breastfeeding even when the mother is CMV-positive, emphasizing its importance for
infant health. They note that the potential benefits of breastfeeding—such as reduced risks of infections, allergies, and chronic diseases—far outweigh the low risk of CMV transmission.
To manage potential risks, some mothers with active CMV infections are advised to practice good hygiene, such as thorough handwashing before handling breast milk or the infant. In specific circumstances, such as maternal primary infection during pregnancy, additional precautions may be taken, and close monitoring is advised.
In conclusion, while CMV can be present in breast milk and can be transmitted to infants, the overall risk remains low for healthy, full-term babies. The benefits of breastfeeding are well-documented and generally outweigh the potential risks associated with CMV. For preterm or immunocompromised infants, healthcare providers may recommend specific measures to mitigate risk, but in most cases, breastfeeding remains highly encouraged. Ongoing research continues to refine guidelines, aiming to protect infants while supporting maternal-infant bonding and nutrition.
